{
    "Trade/Device Name(s)": [
        "eBchek Blood Glucose Monitoring System"
    ],
    "Submitter Information": "Visgeneer Inc.",
    "510(k) Number": "K122181",
    "Predicate Device Reference 510(k) Number(s)": [
        "K062555"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGA",
        "NBW",
        "JJX"
    ],
    "Summary Letter Date": "August 15, 2013",
    "Summary Letter Received Date": "August 8, 2013",
    "Submission Date": "July 31, 2013",
    "Regulation Number(s)": [
        "21 CFR 862.1345",
        "21 CFR 862.1660"
    ],
    "Regulation Name(s)": [
        "Glucose test system",
        "Single (specified) analyte controls (assayed and unassayed)"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Glucose"
    ],
    "Specimen Type(s)": [
        "Fresh capillary whole blood"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "eBchek Meter"
    ],
    "Method(s)/Technology(ies)": [
        "Electrochemical biosensor"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Analyzer",
        "Test Strip",
        "Control Solution",
        "Accessory"
    ],
    "Document Summary": "FDA 510(k) summary for Visgeneer Inc. eBchek Blood Glucose Monitoring System for home use glucose measurement using electrochemical biosensor.",
    "Indications for Use Summary": "For quantitative measurement of glucose in fresh capillary whole blood from the fingertip for self-testing by a single person with diabetes at home; not for diagnosis/screening or neonatal use.",
    "fda_folder": "Clinical Chemistry"
}